阿立哌唑血药浓度即时检测:开发、验证与实用性
该研究开发并验证了一种用于指尖毛细血管血阿立哌唑浓度检测的即时检测(POC)分析仪(MyCare™ Insite),并在14个月内对101例患者同步比较毛细血管POC法与常规静脉实验室法。两种方法相关系数r为0.96,斜率0.91、截距4 ng/mL,偏差极小,提示该POC分析仪足够准确可靠,可用于临床评估阿立哌唑依从性和优化给药。
要点
- MyCare™ Insite POC分析仪6分钟可测指尖血阿立哌唑浓度。
- 101例患者同步比较,POC法与实验室法相关系数r=0.96。
- 两种方法偏差极小(斜率0.91,截距4 ng/mL),支持临床应用。
核心结论
- MyCare Insite POC分析仪足够准确可靠,可用于临床检测阿立哌唑血药浓度。
研究设计与样本
- 研究在2021年7月开始的14个月内进行,用加标全血和不同浓度对照样本建立分析性能,并对101例患者同步采集指尖毛细血管血与常规静脉血进行比较。
主要发现
- 101例患者同意采用两种方法测量,实验室法静脉血阿立哌唑浓度为17至909 ng/mL,POC法为1至791 ng/mL。
- 两种方法相关系数r为0.96,偏差极小(斜率0.91,截距4 ng/mL)。
关键数值与推荐
- POC分析仪在6分钟内提供阿立哌唑浓度测量结果。
临床怎么用
- 该POC技术可改善阿立哌唑治疗依从性评估并有助于优化阿立哌唑剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The antipsychotic aripiprazole is often used in the treatment of first-episode psychosis. Measuring aripiprazole blood levels provides an objective measure of treatment adherence, but this currently involves taking a venous blood sample and sending to a laboratory for analysis. AIMS: To detail the development, validation and utility of a new point of care (POC) test for finger-stick capillary blood concentrations of aripiprazole. METHOD: Analytical performance (sensitivity, precision, recovery and linearity) of the assay were established using spiked whole blood and control samples of varying aripiprazole concentration. Assay validation was performed over a 14-month period starting in July 2021. Eligible patients were asked to provide a finger-stick capillary sample in addition to their usual venous blood sample. Capillary blood samples were tested by the MyCare™ Insite POC analyser, which provided measurement of aripiprazole concentration in 6 min, and the venous blood sample was tested by the standard laboratory method. RESULTS: A total of 101 patients agreed to measurements by the two methods. Venous blood aripiprazole concentrations as assessed by the laboratory method ranged from 17 to 909 ng/mL, and from 1 to 791 ng/mL using POC testing. The correlation coefficient between the two methods (r) was 0.96 and there was minimal bias (slope 0.91, intercept 4 ng/ml). CONCLUSIONS: The MyCare Insite POC analyser is sufficiently accurate and reliable for clinical use. The availability of this technology will improve the assessment of adherence to aripiprazole and the optimising of aripiprazole dosing.
引用
- Atkins M, Taylor D, Catalan A, et al. Point of care assay for blood aripiprazole concentrations: development, validation and utility. Br J Psychiatry. 2023. PMID: 37254587. doi:10.1192/bjp.2023.58
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。